Pharmaceutical
Home » Angioedema Treatment Market

Angioedema Treatment Market

Angioedema Treatment Market By Treatments (Antihistamines, Cortecosteroids, Autoimmune Drugs, Antifibrinolytic Agents, Blood Protein Controllers), By Pipeline (Phase I, Phase II, Phase III) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Report Book

Published Date: Jul. 2016
Category: Pharmaceuticals
Report ID: 58017
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

Growth in healthcare investments, the prevalence of angioedema, and a growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years, the demand for angioedema treatment is expected to increase significantly in economies such as China and Japan. The rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.

The treatments studied for analyzing the overall angioedema treatment market are antihistamines, corticosteroids, autoimmunity drugs, antifibrinolytic agents, and blood protein controllers. The market size and forecast for each of these segments for the period 2014–2022 are provided in this study, along with respective CAGRs for the forecast period 2016–2022. This report also highlights information about major clinical trial candidates under scrutiny for angioedema treatment. These candidates are categorized corresponding to their trial phases, namely phases I, II, and III.

Geographically, the global angioedema treatment market is studied for the following regional markets:

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

The market size and forecast for these regional and country-level markets are presented in this study for the period 2014–2022. Market growth rates for the forecast period 2016–2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global angioedema treatment market. Tools such as the market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global angioedema treatment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the angioedema treatment market.

Based on the type of treatment, the global angioedema treatment market is segmented as follows:

  • Antihistamines
  • Corticosteroid
  • Autoimmune Drugs
  • Antifibrinolytic Agents
  • Blood protein controllers

Angioedema, also known as angioneurotic edema, is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa, and submucosal tissues. Angioedema is a common condition caused by allergies and shows up as sudden swelling under the skin surface. Angioedema can be caused by allergies to food, medications, environmental factors, genetic reasons, and common allergens. There are four common forms of angioedema, such as allergic angioedema, idiopathic angioedema, drug-induced angioedema, and hereditary angioedema. The treatments for angioedema include a normal physical examination and proper drugs for the prevention of attacks in the patients. The drugs’ treatments include antihistamines, corticosteroids, autoimmunity drugs, antifibrinolytic agents, and blood protein controllers. Antihistamines and corticosteroids accounted for approximately 45%–50% of the total market share because these are the first-line therapies preferred by medical practitioners and majorly used as supportive therapies and the most accessible source of treatment across the globe.

For the purpose of this study, the global angioedema treatment market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

The geographical segmentation of the global market for angioedema treatment comprises North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. In the base year 2015, North America accounted for the largest market in the angioedema treatment market due to the rising number of angioedema patients in the U.S. along with the rising awareness among the patients, which are the key factors contributing towards the growth of the angioedema treatment market in this region. In North America, an estimated 20% of the population is affected by angioedema. Contemporary medical management of angioedema is divided between the treatment of acute attacks and short- and long-term prophylaxis to reduce both the frequency and severity of subsequent flare-ups.

Worldwide, the incidence of angioedema is approximately 1 in 30,000 to 50,000 persons. Europe held the second-largest market in the angioedema treatment market. The high prevalence rate of angioedema in Europe is the driving factor for the growth of the market. Moreover, the rising government initiative to increase awareness regarding angioedema would further grow the market in Europe. Asia Pacific is expected to be the fastest-growing market in the global angioedema market due to rising prevalence rates in countries like Japan, China, and others. Moreover, the growing research and development in the drug discovery of angioedema would further drive the market during the forecast period.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Angioedema Treatment Market Portaiture
2.2 Global Angioedema Treatment Market, by Treatment, 2015 (USD Mn)
2.3 Angioedema Treatment Market Share, by Geography, 2015 (Value %)

Chapter 3 Angioedema Treatment : Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.2 Rising Geriatric Population
3.3.1.3 Government Initiative
3.3.2 Challenges
3.3.2.1 Slow Responding Commercialization Of New & Effective Therapies
3.3.3 Opportunities
3.3.3.1 Technological Advancements
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis By Key Players, 2015 (Value %)

Chapter 4 Global Angioedema Treatment Market, by Treatments
4.1 Preface
4.2 Antihistamines
4.1 Cortecosteroids
4.2 Autoimmune Drugs
4.1 Antifibrinolytic Agents
4.2 Blood Protein Controllers

Chapter 5 Global Angioedema Treatment Market, By Pipeline Treatment Analysis
4.3 Overview
4.3 Phase I
4.3 Phase II
4.3 Phase III

Chapter 6 Global Angioedema Treatment Market, By Geography
6.1 Overview
6.2 North America
4.2.1. U.S.
4.2.2. Canada
6.3 Europe
4.2.1. U.K.
4.2.2. Germany
4.2.3. Rest of Europe
6.4 Asia Pacific
4.2.1. Japan
4.2.2. China
4.2.3. Rest of Asia Pacific
6.4 Latin America
6.5 Middle East and Africa

Chapter 7 Company Profiles
7.1 AstraZeneca plc
7.1.1 Business Description
7.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
7.1.4 News Coverage
7.2 F. Hoffmann-La Roche AG
7.2.1 Business Description
7.2.2 Financial Health and Budget Allocation
7.2.3 Product Portfolio
7.2.4 News Coverage
7.3 Valeant Pharmaceuticals International.
7.3.1 Business Description
7.3.2 Financial Health and Budget Allocation
7.3.3 Product Portfolio
7.3.4 News Coverage
7.4 Merck & Co.
7.4.1 Business Description
7.4.2 Financial Health and Budget Allocation
7.4.3 Product Portfolio
7.4.4 News Coverage
7.5 Dyax Corp
7.5.1 Business Description
7.5.2 Financial Health and Budget Allocation
7.5.3 Product Portfolio
7.5.4 News Coverage
7.6 CSL Behring
7.6.1 Business Description
7.6.2 Financial Health and Budget Allocation
7.6.3 Product portfolio
7.6.4 News Coverage
7.7 Pharming Group
7.7.1 Business Description
7.7.2 Financial Health and Budget Allocation
7.7.3 Product Portfolio
7.7.4 News Coverage
7.8 ViroPharma
7.8.1 Business Description
7.8.2 Financial Health and Budget Allocation
7.8.3 Product Portfolio
7.8.4 News Coverage
7.9 Other Notable Players

List of Figures

FIG. 1 Global Angioedema Treatment Market, by Treatment, 2015 (USD Mn)
FIG. 2 Global Angioedema Treatment Market Share, by Geography, 2015 (Value %)
FIG. 3 Attractive Investment Proposition, Global Angioedema Treatment Market, 2015
FIG. 4 Market Share Analysis By Key Players, 2015 (Value %)
FIG. 5 Global Antihistamines Market Revenue, 2013 – 2022 (USD Mn)
FIG. 6 Global Cortecosteroid Market Revenue, 2013 – 2022 (USD Mn)
FIG. 7 Global Autoimmune Drugs Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Antifibrinolytic Agents Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Blood Protein Controllers Market Revenue, 2013 – 2022 (USD Mn)

List of Tables

TABLE 1 Global Angioedema Treatment Revenue, by Treatment Type, 2013 – 2022 (USD Mn)
TABLE 2 Global Angioedema Treatment Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 3 Angioedema Pipeline Analysis (Phase I)
TABLE 4 Angioedema Pipeline Analysis (Phase II)
TABLE 5 Angioedema Pipeline Analysis (Phase III)
TABLE 6 North America Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Europe Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Asia – Pacific Angioedema Treatment Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 8 Latin America Angioedema Treatment Market Revenue, by Regions, 2013 – 2022 (USD Mn)

Frequently Asked Question

What is the size of Angioedema Treatment Market?

The market for Angioedema Treatment Market is expected to reach USD$ XX Mn in 2022.

What is the Angioedema Treatment Market CAGR?

TheAngioedema Treatment Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Angioedema Treatment Market?

The report is forecasted from 2016 -2022.

What is the base year considered for Angioedema Treatment Market?

The base year of this report is 2015.

Who are the major players in this market?

AstraZeneca plc, F. Hoffmann-La Roche AG, Valeant Pharmaceuticals International., Merck & Co . are some of the major players in the global market.

Healthcare

Trientine Hydrochloride Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 58081
Report Format: PDF
No of Pages: 247

Pharmaceutical

Pharmaceutical Chemicals Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62118
Report Format: PDF
No of Pages: 247

Pharmaceutical

Wilson’s Disease Drugs Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 58947
Report Format: PDF
No of Pages: 190

Healthcare

Stretch Marks Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62116
Report Format: PDF
No of Pages: 221

Pharmaceutical

Fetal Bovine Serum Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62115
Report Format: PDF
No of Pages: 238

Healthcare

Cirrhosis Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62114
Report Format: PDF
No of Pages: 229

Pharmaceutical

Congenital Hyperinsulinism Treatment Market

Published Date: Sept 2023
Category: Pharmaceuticals
Report ID: 62113
Report Format: PDF
No of Pages: 219

Healthcare

Cryptococcal Meningitis Treatment Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62112
Report Format: PDF
No of Pages: 237

Healthcare

Dermatology Endoscopy devices Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62111
Report Format: PDF
No of Pages: 237

Healthcare

Cementless Total Knee Arthroplasty Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62110
Report Format: PDF
No of Pages: 228

Healthcare

Cell & Gene Therapy Clinical Trials Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62109
Report Format: PDF
No of Pages: 228

HealthCare

Self-sampling Blood Collection and Storage Device Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 61352
Report Format: PDF
No of Pages: 234

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now